Advertisement

Topics

PharmAbcine Inc. Company Profile

20:07 EST 18th December 2018 | BioPortfolio

PharmAbcine is a leading clinical stage biologics company that develops fully human therapeutic antibody (mAb) and next generation multispecific antibody therapeutics based on in-house developed novel platform, DIG-Body, PIG-Body and TIG-Body using innovative discovery technology and excellent human resources for the treatment of human diseases, such as cancer and inflammatory diseases.


News Articles [6 Associated News Articles listed on BioPortfolio]

Interview: PharmAbcine's Hopes Rise As Tanibirumab Set For Keytruda Combo Trials

PharmAbcine CEO Jin-San Yoo talks to Scrip about the company’s overseas clinical trial strategy, pipeline assets, and ambitions for lead...   

PharmAbcine Announces FDA Accepts IND Application of TTAC-0001 for the Treatment of Recurrent ...

Read more...

IPO Update: August Had A Slow Start, But New US Filings Hint At Busy September

There were only two biopharma IPOs in the US during August, bringing the year's total to 47. But with eight...   

Pay Day For Reata As Bardoxolone Progresses For Kidney Disease In Japan

Reata reaps benefit from 2009 licensing deal with Kyowa Hakko Kirin for bardoxolone as transcription factor activator moves into pivotal...   

PharmAbcine Announces FDA Accepts IND Application of TTAC-0001 for the Treatment of Recurrent Glioblastoma

PharmAbcine, Inc, a clinical-stage biotech company developing novel antibody therapeutics for multiple cancer indications announces that the company received “Study May P...

PharmAbcine Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 10052018] Prices from USD $250

SummaryPharmAbcine Inc PharmAbcine is a biotechnology company that discovers and develops human therapeutic monoclonal antibodies. The company offers lead MAB and bispecific MAB products. It provides ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

PharmAbcine Inc.

PharmAbcine is a leading clinical stage biologics company that develops fully human therapeutic antibody (mAb) and next generation multispecific antibody therapeutics based on in-...

PharmAbcine

PharmAbcine is a specialized biotech company that develops fully human therapeutic monoclonal antibody (mAb) using innovative discovery technology and excellent human resources for the treatment of hu...

More Information about "PharmAbcine Inc." on BioPortfolio

We have published hundreds of PharmAbcine Inc. news stories on BioPortfolio along with dozens of PharmAbcine Inc. Clinical Trials and PubMed Articles about PharmAbcine Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PharmAbcine Inc. Companies in our database. You can also find out about relevant PharmAbcine Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record